What is the projected market valuation of the Veterinary CRO and CDMO Market by 2035?

The Veterinary CRO and CDMO Market is projected to reach a valuation of 17.47 USD Billion by 2035. Read More

What was the market valuation of the Veterinary CRO and CDMO Market in 2024?

In 2024, the market valuation of the Veterinary CRO and CDMO Market was 7.34 USD Billion. Read More

What is the expected CAGR for the Veterinary CRO and CDMO Market during the forecast period 2025 - 2035?

The expected CAGR for the Veterinary CRO and CDMO Market during the forecast period 2025 - 2035 is 8.2%. Read More

Which therapeutic area is projected to have the highest market growth in the Veterinary CRO and CDMO Market?

The Infectious Diseases therapeutic area is projected to grow from 2.67 USD Billion in 2024 to 6.47 USD Billion by 2035. Read More

What are the key segments of the Veterinary CRO and CDMO Market?

Key segments include Drug Development, Toxicology and Safety, and Manufacturing, among others. Read More

Which company is a leading player in the Veterinary CRO and CDMO Market?

Covance, based in the US, is recognized as a leading player in the Veterinary CRO and CDMO Market. Read More

What is the projected growth for the Manufacturing segment in the Veterinary CRO and CDMO Market?

The Manufacturing segment is expected to grow from 1.84 USD Billion in 2024 to 4.27 USD Billion by 2035. Read More

How does the market for small animals compare to livestock in the Veterinary CRO and CDMO Market?

The market for livestock is projected to grow from 3.0 USD Billion in 2024 to 7.0 USD Billion by 2035, surpassing the small animals segment. Read More

What services are included in the Clinical Trial Support segment of the Veterinary CRO and CDMO Market?

The Clinical Trial Support segment includes services related to the management and execution of clinical trials for veterinary products. Read More

What is the anticipated growth for the Bioanalysis segment in the Veterinary CRO and CDMO Market?

The Bioanalysis segment is projected to grow from 1.0 USD Billion in 2024 to 2.4 USD Billion by 2035. Read More

Veterinary CRO and CDMO Market

ID: MRFR/HC/24696-HCR

128 Pages

Satyendra Maurya

Last Updated: May 15, 2026

Veterinary CRO and CDMO Market Size, Growth Research Report By Application (Drug Development, Toxicology and Safety, Pharmacokinetics and Metabolism, Bioanalysis, Manufacturing), By Service Type (Discovery and Development, Clinical Trial Support, Manufacturing and Packaging, Regulatory Affairs), By Therapeutic Area (Oncology, Cardiovascular, Neurology, Immunology, Infectious Diseases), By Animal Type (Small Animals (Dogs, Cats), Livestock (Cattle, Pigs, Poultry), Aquatic Animals (Fish, Shrimp), Laboratory Animals (Mice, Rats)) - Competitor Industry Analysis and Trends Forecast Till 2035

Veterinary CRO and CDMO Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.2%

2024 Market Size$ 7.34 Billion

2025 Market Size$ 7.94 Billion

2035 Market Size$ 17.47 Billion

Key Players

Covance

Charles River Laboratories

Eligo Bioscience

PRA Health Sciences

Wuxi AppTec

Kymab

Trends

Technological Advancements in Research
Increased Focus on Animal Welfare
Outsourcing Trends Among Pharmaceutical Companies

Opportunities

Rising Demand for Animal Health Products
Growing Investment in Veterinary Research
Regulatory Support for Veterinary Innovations

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Billion) | |
  1. 4.1.1 Drug Development | |
  2. 4.1.2 Toxicology and Safety | |
  3. 4.1.3 Pharmacokinetics and Metabolism | |
  4. 4.1.4 Bioanalysis | |
  5. 4.1.5 Manufacturing |
2. 4.2 Healthcare, BY Service Type (USD Billion) | |
  1. 4.2.1 Discovery and Development | |
  2. 4.2.2 Clinical Trial Support | |
  3. 4.2.3 Manufacturing and Packaging | |
  4. 4.2.4 Regulatory Affairs |
3. 4.3 Healthcare, BY Therapeutic Area (USD Billion) | |
  1. 4.3.1 Oncology | |
  2. 4.3.2 Cardiovascular | |
  3. 4.3.3 Neurology | |
  4. 4.3.4 Immunology | |
  5. 4.3.5 Infectious Diseases |
4. 4.4 Healthcare, BY Animal Type (USD Billion) | |
  1. 4.4.1 Small Animals (Dogs, Cats) | |
  2. 4.4.2 Livestock (Cattle, Pigs, Poultry) | |
  3. 4.4.3 Aquatic Animals (Fish, Shrimp) | |
  4. 4.4.4 Laboratory Animals (Mice, Rats) |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Covance (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Charles River Laboratories (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Eligo Bioscience (FR) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 PRA Health Sciences (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Wuxi AppTec (CN) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Kymab (GB) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Eurofins Scientific (LU) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Medpace (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Syneos Health (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY SERVICE TYPE |
8. 6.5 US MARKET ANALYSIS BY THERAPEUTIC AREA |
9. 6.6 US MARKET ANALYSIS BY ANIMAL TYPE |
10. 6.7 CANADA MARKET ANALYSIS BY APPLICATION |
11. 6.8 CANADA MARKET ANALYSIS BY SERVICE TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY THERAPEUTIC AREA |
13. 6.10 CANADA MARKET ANALYSIS BY ANIMAL TYPE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION |
16. 6.13 GERMANY MARKET ANALYSIS BY SERVICE TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY THERAPEUTIC AREA |
18. 6.15 GERMANY MARKET ANALYSIS BY ANIMAL TYPE |
19. 6.16 UK MARKET ANALYSIS BY APPLICATION |
20. 6.17 UK MARKET ANALYSIS BY SERVICE TYPE |
21. 6.18 UK MARKET ANALYSIS BY THERAPEUTIC AREA |
22. 6.19 UK MARKET ANALYSIS BY ANIMAL TYPE |
23. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION |
24. 6.21 FRANCE MARKET ANALYSIS BY SERVICE TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY THERAPEUTIC AREA |
26. 6.23 FRANCE MARKET ANALYSIS BY ANIMAL TYPE |
27. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION |
28. 6.25 RUSSIA MARKET ANALYSIS BY SERVICE TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY THERAPEUTIC AREA |
30. 6.27 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE |
31. 6.28 ITALY MARKET ANALYSIS BY APPLICATION |
32. 6.29 ITALY MARKET ANALYSIS BY SERVICE TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY THERAPEUTIC AREA |
34. 6.31 ITALY MARKET ANALYSIS BY ANIMAL TYPE |
35. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION |
36. 6.33 SPAIN MARKET ANALYSIS BY SERVICE TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY THERAPEUTIC AREA |
38. 6.35 SPAIN MARKET ANALYSIS BY ANIMAL TYPE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC AREA |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY APPLICATION |
45. 6.42 CHINA MARKET ANALYSIS BY SERVICE TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY THERAPEUTIC AREA |
47. 6.44 CHINA MARKET ANALYSIS BY ANIMAL TYPE |
48. 6.45 INDIA MARKET ANALYSIS BY APPLICATION |
49. 6.46 INDIA MARKET ANALYSIS BY SERVICE TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY THERAPEUTIC AREA |
51. 6.48 INDIA MARKET ANALYSIS BY ANIMAL TYPE |
52. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION |
53. 6.50 JAPAN MARKET ANALYSIS BY SERVICE TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY THERAPEUTIC AREA |
55. 6.52 JAPAN MARKET ANALYSIS BY ANIMAL TYPE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION |
61. 6.58 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC AREA |
63. 6.60 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE |
64. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION |
65. 6.62 THAILAND MARKET ANALYSIS BY SERVICE TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY THERAPEUTIC AREA |
67. 6.64 THAILAND MARKET ANALYSIS BY ANIMAL TYPE |
68. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION |
69. 6.66 INDONESIA MARKET ANALYSIS BY SERVICE TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY THERAPEUTIC AREA |
71. 6.68 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION |
73. 6.70 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC AREA |
75. 6.72 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION |
78. 6.75 BRAZIL MARKET ANALYSIS BY SERVICE TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY THERAPEUTIC AREA |
80. 6.77 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE |
81. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION |
82. 6.79 MEXICO MARKET ANALYSIS BY SERVICE TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY THERAPEUTIC AREA |
84. 6.81 MEXICO MARKET ANALYSIS BY ANIMAL TYPE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION |
86. 6.83 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC AREA |
88. 6.85 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC AREA |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC AREA |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION |
103. 6.100 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC AREA |
105. 6.102 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY ANIMAL TYPE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Veterinary CRO and CDMO Market Segmentation

Veterinary CRO and CDMO Market By Application (USD Billion, 2025-2035)

Drug Development
Toxicology and Safety
Pharmacokinetics and Metabolism
Bioanalysis
Manufacturing

Veterinary CRO and CDMO Market By Service Type (USD Billion, 2025-2035)

Discovery and Development
Clinical Trial Support
Manufacturing and Packaging
Regulatory Affairs

Veterinary CRO and CDMO Market By Therapeutic Area (USD Billion, 2025-2035)

Oncology
Cardiovascular
Neurology
Immunology
Infectious Diseases

Veterinary CRO and CDMO Market By Animal Type (USD Billion, 2025-2035)

Small Animals (Dogs, Cats)
Livestock (Cattle, Pigs, Poultry)
Aquatic Animals (Fish, Shrimp)
Laboratory Animals (Mice, Rats)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”